Access to the life science market can be a headache for multinational pharma and medical device companies, let alone small-medium sized enterprises (SMEs). SMEs can face significant challenges to introduce new and innovative products into the health and social care market.
The Innovation Nexus provides a single point of access for SMEs in the life science sector to a network of specialist support within Greater Manchester.
The Innovation Nexus is a gateway to a holistic business growth support offering, focused on the specialist needs of life science SMEs, delivered through a coherent support strategy and an all-inclusive approach to helping businesses develop their growth strategies.
The aim of the Innovation Nexus is to deliver long-term health and wealth benefits to Greater Manchester through investment, innovation, education and business growth, ultimately improving the health and wellbeing of the Greater Manchester population (and beyond).
INDUSTRY PARTNERSHIP WILL BE A KEY COMPONENT OF HOW HEALTH SYSTEMS WILL IMPROVE HEALTH OUTCOMES FOR THE POPULATIONS THEY SERVE
The challenge for healthcare businesses
Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.
How can the Innovation Nexus help?
Help with navigating NHS procurement
Information about funding and investment
Help with setting up a trial of your innovation
Information on science parks and office locations in the GM AHSN footprint
Connections to organisations that can help you progress your innovation
Speak directly to a GM AHSN advisor with NHS expertise
NHS Innovation and Technology Payment (ITP)
In his speech at last week's NHS Confederation Conference, Simon Stevens, Chief Executive of NHS England, announced the launch of the NHS Innovation and Technology Payment (ITP). This programme builds on the Innovation and Technology Tariff (ITT) which went live on 1 April 2017.
The ITP aims to support the NHS in adopting innovation by removing financial or procurement barriers to uptake of innovative products or technologies. This programme will be delivered in partnership with the AHSNs, sponsors, national and international experts.
Innovations (specifically medical devices, digital platforms and technologies) accepted on to the ITP will inform an innovation or technology theme, which will then be incentivised via financial or procurement support. This will enable the successful applicant’s innovation - along with any others that meet the same criteria - to be incentivised for use in the NHS.
Any payment, tariff or purchase of products will be available to the NHS from April 2018 for a period of one year, at which point the programme and themes will be reviewed.
The ITP is now inviting expressions of interest via NHS England’s Innovation Exchange: http://www.innovation.england.nhs.uk/en/itp. Applications will open on 17 July 2017 and the deadline for completed applications is noon on 8 September 2017.
Full application guidance notes for the ITP are available here.
Information and guidance
Access information and guidance on a range of topics related to working with and selling to the NHS, and find clear signposts to organisations that can help you achieve your goals.